Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleLaboratory Studies

Pretargeted Immunoscintigraphy: Effect of Hapten Valency on Murine Tumor Uptake

David A. Goodwin, Claude F. Meares, Maureen McTigue, Warak Chaovapong, Carol I. Diamanti, Charles H. Ransone and Michael J. McCall
Journal of Nuclear Medicine November 1992, 33 (11) 2006-2013;
David A. Goodwin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claude F. Meares
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maureen McTigue
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Warak Chaovapong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol I. Diamanti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles H. Ransone
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. McCall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 33 no. 11 2006-2013
PubMed 
1432163

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X

Copyright & Usage 
COPYRIGHT © 1992 by The Society of Nuclear Medicine, Inc.

Author Information

Statistics from Altmetric.com

Cited By...

  • 46 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: March 2001 to January 2023

AbstractFullPdf
Feb 2001100
Apr 2001200
Jun 2002300
Sep 2002100
Dec 2002100
Feb 2003200
Jul 2003200
Aug 2003500
Sep 2003200
Oct 2003400
Nov 2003800
Dec 2003400
Jan 2004500
Feb 2004500
Mar 2004700
Apr 2004500
May 2004400
Jun 20041800
Jul 20042200
Aug 2004900
Sep 2004100
Oct 2004300
Nov 2004200
Dec 2004200
Jan 2005200
Feb 2005600
Mar 2005400
Jun 2005100
Aug 2005100
Oct 2005100
Nov 2005100
Dec 2005400
Jan 2006200
Feb 2006100
Jul 2006200
Oct 2006100
Jan 2007203
Feb 2007208
Apr 2007301
May 2007600
Jun 2007201
Jul 2007006
Aug 2007004
Sep 2007103
Oct 2007304
Nov 2007003
Dec 2007002
Jan 2008103
Feb 2008203
Mar 2008105
Apr 2008006
May 2008004
Jun 2008608
Jul 20083019
Aug 2008603
Sep 2008603
Oct 2008106
Nov 20084010
Dec 2008200
Jan 2009102
Feb 2009001
Mar 2009204
May 2009001
Jun 2009101
Jul 2009102
Aug 2009201
Sep 2009102
Oct 2009006
Nov 2009405
Dec 2009002
Jan 20101010
Feb 2010002
Mar 2010201
Apr 2010104
May 2010100
Jun 2010302
Jul 2010001
Aug 2010201
Sep 2010207
Oct 2010102
Nov 2010502
Dec 2010304
Jan 2011302
Feb 2011500
Mar 2011100
Apr 2011202
May 2011100
Jun 2011003
Jul 2011006
Aug 20110013
Sep 20110011
Oct 2011005
Nov 2011002
Dec 2011003
Jan 2012003
Feb 2012004
Mar 2012003
Apr 2012007
May 2012004
Jun 2012005
Jul 2012001
Aug 2012001
Sep 2012001
Oct 2012002
Nov 2012003
Jan 2013002
Feb 2013003
Mar 2013006
Apr 2013007
May 2013004
Jun 2013008
Jul 2013001
Aug 2013003
Dec 2013002
Feb 2014003
Mar 2014003
Apr 2014003
May 2014003
Jun 2014002
Jul 2014001
Aug 2014001
Oct 2014003
Nov 2014005
Jan 2015001
Feb 2015005
Mar 2015005
Apr 2015001
May 2015004
Jun 2015003
Jul 20150011
Aug 2015004
Sep 2015002
Nov 2015005
Dec 2015005
Jan 2016003
Feb 2016007
Mar 20160110
Apr 20160012
May 20160014
Jun 2016005
Jul 20160012
Aug 20160010
Sep 2016007
Oct 20160019
Nov 2016002
Dec 2016002
Jan 2017005
Feb 2017001
Mar 2017002
May 2017006
Aug 2017002
Oct 2017001
Nov 2017001
Dec 2017003
Jan 2018004
Feb 2018001
Mar 2018002
Apr 2018001
Jun 2018001
Jul 2018001
Feb 2019001
Mar 2019001
Apr 2019003
May 2019001
Jun 2019001
Jul 2019002
Aug 2019003
Sep 20190025
Nov 2019003
Mar 2020001
Apr 2020002
May 2020002
Jun 2020001
Jul 2020001
Aug 2020003
Sep 2020001
Oct 2020008
Dec 2020004
Jan 2021006
Feb 2021001
Mar 2021004
Apr 2021003
May 2021003
Jun 2021102
Jul 2021504
Aug 2021002
Sep 2021101
Oct 2021004
Nov 2021006
Dec 2021006
Jan 2022005
Feb 2022002
Mar 2022003
Apr 2022002
Jun 2022101
Jul 2022005
Aug 2022006
Sep 2022003
Oct 2022103
Nov 2022002
Dec 20221010
Jan 2023109
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 33, Issue 11
November 1, 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pretargeted Immunoscintigraphy: Effect of Hapten Valency on Murine Tumor Uptake
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Pretargeted Immunoscintigraphy: Effect of Hapten Valency on Murine Tumor Uptake
David A. Goodwin, Claude F. Meares, Maureen McTigue, Warak Chaovapong, Carol I. Diamanti, Charles H. Ransone, Michael J. McCall
Journal of Nuclear Medicine Nov 1992, 33 (11) 2006-2013;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pretargeted Immunoscintigraphy: Effect of Hapten Valency on Murine Tumor Uptake
David A. Goodwin, Claude F. Meares, Maureen McTigue, Warak Chaovapong, Carol I. Diamanti, Charles H. Ransone, Michael J. McCall
Journal of Nuclear Medicine Nov 1992, 33 (11) 2006-2013;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting
  • Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
  • Improving the Delivery of Radionuclides for Imaging and Therapy of Cancer Using Pretargeting Methods
  • Reagents and Methods for PET Using Bispecific Antibody Pretargeting and 68Ga-Radiolabeled Bivalent Hapten-Peptide-Chelate Conjugates
  • A Universal Pretargeting System for Cancer Detection and Therapy Using Bispecific Antibody
  • Molecular Advances in Pretargeting Radioimunotherapy with Bispecific Antibodies
  • Pretargeting of Renal Cell Carcinoma: Improved Tumor Targeting with a Bivalent Chelate
  • Google Scholar

More in this TOC Section

  • Assessment of Cancer Recurrence in Residual Tumors after Fractionated Radiotherapy: A Comparison of Fluorodeoxyglucose, L-Methionine and Thymidine
  • Monitoring Gene Therapy with Herpes Simplex Virus Thymidine Kinase in Hepatoma Cells: Uptake of Specific Substrates
  • Technetium-99m Labeling and Biodistribution of Anti-TAC Disulfide-Stabilized Fv Fragment
Show more Laboratory Studies

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire